文献速递神经核医学肿瘤 PET/CT

18F-FDG PET显示白血病化疗后脑葡萄糖摄取基于体素的降低:回顾性匹配对照研究

18F-FDG PET Reveals Voxel-Based Decreases in Brain Glucose Uptake After Chemotherapy in Leukemia Patients: A Retrospective Matched-Control Study.
PubMed 文献 · J Nucl Med · 2025-12-03

该回顾性研究纳入100例成人白血病患者,按化疗暴露分组(近期≤1年、既往>1年、未化疗对照),用高分辨率[18F]FDG PET/CT评估脑葡萄糖代谢的体素改变。化疗暴露者后扣带回、前眶回和丘脑摄取显著降低;≥55岁者中央盖及额下回代谢降低;近期化疗者梭状回代谢增高;鞘内化疗与丘脑代谢降低相关。

要点

  • 化疗暴露者后扣带回、前眶回和丘脑FDG摄取较对照显著降低。
  • ≥55岁患者中央盖和额下回代谢降低更明显。
  • 鞘内化疗与丘脑代谢降低相关,近期化疗者梭状回代谢增高。

核心结论

  • 化疗与基于体素的脑代谢改变相关,尤其在认知和情绪相关脑区。
  • 效应在老年人和接受鞘内化疗者中更明显。

研究设计与样本

  • 回顾性研究纳入100例成人白血病患者(新诊断和复发),按化疗暴露分为近期(≤1年,49例)、既往(>1年,22例)和未化疗对照(29例)。
  • 使用高分辨率[18F]FDG PET/CT脑显像,MIM软件量化脑代谢并归一化至参考区。
  • 统计分析采用t检验和ANOVA,校正年龄和性别。

主要发现

  • 化疗暴露者后扣带回摄取1.33 vs. 1.36(P=0.04)、前眶回1.05 vs. 1.11(P=0.05)、丘脑1.19 vs. 1.24(P=0.05)较对照降低。
  • ≥55岁患者中央盖1.12 vs. 1.19(P<0.001)和额下回1.16 vs. 1.19(P=0.05)代谢降低。
  • 近期化疗者梭状回代谢增高1.34 vs. 1.27(P=0.04)及岛叶,长期生存者无此改变。
  • 鞘内化疗与丘脑代谢降低相关(1.11 vs. 1.15;P=0.02)。

临床怎么用

  • 对白血病化疗后认知或情绪症状患者,可考虑[18F]FDG PET/CT脑代谢评估作为辅助影像标志物。
  • 老年和接受鞘内化疗的患者可能代谢改变更明显,解读脑PET时需结合化疗史。

局限性

  • 回顾性设计可能存在选择偏倚。
  • 样本量较小,部分亚组例数有限。
  • 未报告认知功能评分与代谢改变的直接相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chemotherapy-induced cognitive impairment is increasingly recognized in leukemia survivors. Its underlying neurobiologic correlations remain unclear. This study investigated voxel-based alterations in brain glucose metabolism after chemotherapy using high-resolution [18F]FDG PET/CT. Methods: This retrospective study included 100 adults with leukemia, both newly diagnosed and relapsed, who underwent [18F]FDG PET/CT brain imaging. Patients were grouped by chemotherapy exposure: recent (≤1 y), prior (>1 y), and none (chemotherapy-naïve controls). Brain metabolism was quantified using MIM software and normalized to reference regions. Statistical analysis included t tests and ANOVA, adjusted for age and sex. Results: Among 100 patients (49 recent, 22 prior, and 29 control), chemotherapy-exposed individuals showed significant metabolic alterations compared with controls. Decreased uptake was found in the posterior cingulate gyrus (1.33 vs. 1.36; P = 0.04), anterior orbital gyrus (1.05 vs. 1.11; P = 0.05), and thalami (1.19 vs. 1.24; P = 0.05). In patients aged 55 y or older, reduced metabolism was observed in the Rolandic operculum (1.12 vs. 1.19; P < 0.001) and inferior frontal gyrus (1.16 vs. 1.19; P = 0.05). Recent chemotherapy recipients showed increased metabolism in the fusiform gyrus (1.34 vs. 1.27; P = 0.04) and insula, whereas long-term survivors did not. Intrathecal chemotherapy was linked to reduced thalamic metabolism (1.11 vs. 1.15; P = 0.02). Conclusion: Chemotherapy is associated with voxel-based brain metabolic alterations, particularly in areas governing cognition and emotion. Effects are more pronounced in older adults and those receiving intrathecal treatment. These findings support research into metabolic imaging biomarkers for early detection and intervention in chemotherapy-induced cognitive impairment.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Msherghi A, Wong F, Xu G, et al. 18F-FDG PET Reveals Voxel-Based Decreases in Brain Glucose Uptake After Chemotherapy in Leukemia Patients: A Retrospective Matched-Control Study. J Nucl Med. 2025. PMID: 41101978. doi:10.2967/jnumed.125.270661

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。